Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Correction: triple-negative, b...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival

Bibliographic Details
Main Authors: Lee Jeong, Choi Jong, Hong Yun-Chul, Cho Eun, Song Kyug, Park Yeon-Hee, Kim Yeonju, Park Sarah, Oh Ensel, Choi Yoon-La, Kim Jung, Nam Seok, Lim Young-Hyuck, Yang Jung-Hyun, Shin Young
Format: Article
Language:English
Published: BMC 2011-01-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/11/13
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.biomedcentral.com/1471-2407/11/13

Similar Items

  • Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
    by: Kim Jung, et al.
    Published: (2010-09-01)
  • Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
    by: Ji-Yeon Kim, et al.
    Published: (2023-07-01)
  • Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer
    by: Ji-Yeon Kim, et al.
    Published: (2023-03-01)
  • Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer
    by: Eunkyung Han, et al.
    Published: (2024-12-01)
  • Which Clinicopathologic Parameters Suggest Primary Resistance to Palbociclib in Combination With Letrozole as the First-Line Treatment for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer?
    by: Ji-Yeon Kim, et al.
    Published: (2021-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs